These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
59 related articles for article (PubMed ID: 15712395)
21. Recent developments in HIV treatment, Part 2. Boyle BA AIDS Read; 2005 Jun; 15(6):277-9, 284. PubMed ID: 15962449 [No Abstract] [Full Text] [Related]
22. Initiation of antiretroviral therapy: implications of recent findings. Saag MS Top HIV Med; 2004; 12(3):83-8. PubMed ID: 15310939 [TBL] [Abstract][Full Text] [Related]
23. New drugs: amprenavir and abacavir. TreatmentUpdate; 1998 Apr; 10(2):3-4. PubMed ID: 11365435 [TBL] [Abstract][Full Text] [Related]
24. Switching to tenofovir/emtricitabine from abacavir/lamivudine in HIV-infected adults with raised cholesterol: effect on lipid profiles. Behrens G; Maserati R; Rieger A; Domingo P; Abel F; Wang H; Pearce G Antivir Ther; 2012; 17(6):1011-20. PubMed ID: 22910324 [TBL] [Abstract][Full Text] [Related]
25. [New fixed once daily combination as nucleoside backbone. Basis for long-term therapy success]. MMW Fortschr Med; 2005 Apr; 147 Spec No 1():66-8. PubMed ID: 16385881 [No Abstract] [Full Text] [Related]
26. Altered body shape in HIV disease: a side effect of therapy? Baker R; Kotler D; Carr A; Torres RA AIDS Patient Care STDS; 1999 Jul; 13(7):395-402. PubMed ID: 10870593 [TBL] [Abstract][Full Text] [Related]
27. Lipodystrophy in pediatric HIV. Desai N; Mullen P; Mathur M Indian J Pediatr; 2008 Apr; 75(4):351-4. PubMed ID: 18536889 [TBL] [Abstract][Full Text] [Related]
29. Treatment considerations for children with human immunodeficiency virus infection. Pizzo PA; Wilfert CM Pediatr Infect Dis J; 1990 Oct; 9(10):690-9. PubMed ID: 2235141 [No Abstract] [Full Text] [Related]
30. Treatment Trends in Human Immunodeficiency Virus Disease. Proceedings. San Francisco, California, 16 July 1993. J Infect Dis; 1995 Mar; 171 Suppl 2():S79-154. PubMed ID: 7861021 [No Abstract] [Full Text] [Related]
31. Dyslipidemia among HIV-infected patients. Wiwanitkit S; Wiwanitkit V Ann Afr Med; 2014; 13(3):142. PubMed ID: 24923376 [No Abstract] [Full Text] [Related]
32. Progressive lipodystrophy in a male. A case report. Singh A; Krishan I Indian J Med Sci; 1970 Mar; 24(3):149-51. PubMed ID: 5422762 [No Abstract] [Full Text] [Related]
33. Social media use increase testing. AIDS Policy Law; 2015 Feb; 30(3):3. PubMed ID: 26094268 [No Abstract] [Full Text] [Related]
34. Abacavir plus lamivudine: a thymidine analogue-sparing NRTI backbone. Moyle GJ AIDS Read; 2003 Nov; 13(11):528, 533-5. PubMed ID: 14649622 [No Abstract] [Full Text] [Related]
35. Abacavir and lamivudine combination. Somboonwit C; Kurtyka D; Velez AP Expert Opin Drug Metab Toxicol; 2009 Dec; 5(12):1599-606. PubMed ID: 19929448 [TBL] [Abstract][Full Text] [Related]
36. Abacavir/lamivudine/zidovudine continues to be a valid and useful antiretroviral regimen. Shaefer MS Ann Pharmacother; 2004; 38(7-8):1314-6. PubMed ID: 15187204 [No Abstract] [Full Text] [Related]
37. Abacavir: new preparation. Risks limit the value. Prescrire Int; 2000 Jun; 9(47):67-9. PubMed ID: 11010740 [TBL] [Abstract][Full Text] [Related]
38. Abacavir arm stopped in clinical trial. James JS AIDS Treat News; 2003 Apr; (390):6-7. PubMed ID: 12739475 [TBL] [Abstract][Full Text] [Related]
39. The impact of abacavir on lipids and lipodystrophy. Moyle GJ AIDS Read; 2005 Feb; 15(2):62-6. PubMed ID: 15712395 [No Abstract] [Full Text] [Related]